Nattokinase labels run from 2,000 FU to 20,000 FU with nothing on the bottle to tell you which number is right. There is an answer. It sits in a twelve-month study of 1,062 people that tested two doses, and only one of them did anything at all.
By Paul Hendricks
Optimal Health Review · Updated Aug 4, 2026
Nattokinase is a fibrinolytic enzyme. Its job is dissolving fibrin, the protein mesh your body uses to seal small injuries inside the artery wall. It comes from natto, a fermented soybean dish eaten in Japan for a thousand years, and it has been studied in humans since the 1980s.
That part is not controversial. What happens on the shelf is.
Strength here is measured in FU, fibrinolytic units, and this is the one thing to understand before you spend a dollar: FU measures activity, not weight. A label leading with milligrams is describing how much powder is in the capsule, not how much of it still works. Two bottles can both say 200 mg and differ fivefold in the only number that counts.
The uncomfortable part: ConsumerLab tested eight nattokinase supplements bought on the open market in November 2025. Only five delivered activity within an acceptable margin of their own label. One delivered less than half. At least one footnoted that its number applied only “at time of manufacture”, which is true the day it leaves the factory and promises nothing about the day it arrives.
So the question is not which brand markets best. It is narrower, and it has an answer: what dose has actually been tested in people, and which of these bottles matches it?
If more than one of these is true, the rest of this article was written for you.
In 2022, researchers published the largest human study nattokinase has ever had. Chen and colleagues followed 1,062 participants with atherosclerosis and hyperlipidemia for twelve months, in Frontiers in Cardiovascular Medicine. It is the anchor of this entire category, and the reason it matters is not the headline result. It is the design.
They tested two doses.
That single design decision does something no marketing claim can do. It gives this category a floor and a ceiling at the same time.
More is not more proof. Past a point, more is less proof.
Here is where the five best sellers actually land against that number.
* Figures are the manufacturers’ own stated label claims as printed on the bottle or product page, recorded 4 August 2026. Stated activity is not the same as verified activity, which is the subject of the second half of this review.
Keep taking it. We will say that again at the end.
Statins lower cholesterol by inhibiting the rate limiting enzyme of the mevalonate pathway. CoQ10, the cofactor your mitochondria use to produce energy, is manufactured downstream of that same enzyme. So the depletion is not a side effect that sometimes happens. It is the same reaction. A meta analysis of randomised trials found statin therapy significantly reduced circulating CoQ10 versus placebo, across every statin type and dose intensity.
A systematic review in the Journal of the American College of Cardiology concluded the evidence is insufficient to establish that this depletion causes statin associated muscle symptoms. We are telling you before you find it elsewhere. The depletion is settled. The link to your aching legs is not.
Which leaves one narrow claim: your prescription measurably removes something, nothing in your prescription puts it back, and of the five products here, exactly one contains it. Hold onto that until #5.
Five criteria. Two carry double weight, and we want that on the record before you see a score.
How close the label sits to 10,800 FU, in either direction.
Arterial decline is four independent failures: clearing what is already there, blood pressure, calcium routing, and mitochondrial support. How many does the bottle reach?
A batch certificate you can retrieve and read, or a badge. We asked all five companies.
Cost per day against what the capsule is actually capable of doing.
The public review record, including refunds, subscriptions and shipping origin.
Why two carry double weight. They decide whether the product can do the job at all. A company can have flawless service and ship a capsule the research says does nothing. Pleasant to buy from, still not worth buying. You will watch that happen at #4.
Ranked best first. Totals are weighted as described above, which is why the brand with the best formula on paper finishes last.
372 clinicians share this on FrontrowMD without compensation.
Start with the name, because it tells you what the product is trying to be. Every other bottle in this review is named after an ingredient. This one is named after the problem. That is not a branding detail. A product named after one enzyme is arguing, at the moment it asks for your money, that one enzyme is enough.
The dose is the reason it wins. 10,800 FU, matched to the trial rather than rounded up for the front of the bottle. That decision costs a company something. It gives up the biggest number on the shelf and takes the defensible one instead, and it is the only product here where the label and the literature agree.
Then there is the enzyme survival problem nobody else addresses. Nattokinase is a protein. Proteins are fragile in stomach acid. The reason this category runs a horsepower war on the front of the bottle is that nobody is measuring how much survives the trip, so the easy answer is to put more in and hope. Liposomal encapsulation is the other answer to the same question: protect the dose instead of inflating it. No other product in this review competes on this at all.
And it is the only one that reaches all four mechanisms. Nattokinase at the studied dose for fibrin clearance and the PAI-1 brake. Beetroot at 3,000 mg for blood pressure through nitric oxide. Vitamin K2 as MK-7 at 200 mcg for calcium routing, which the Rotterdam Study of 4,807 people tied to less arterial calcification. Berberine at 500 mg for glucose and lipid handling. And CoQ10 as ubiquinol at 200 mg, the thing the statin subtracts.
It is also the only product here with clinicians attached to it by name. 372 of them share it through FrontrowMD, a platform that verifies licensure and states plainly that the clinicians are not compensated for it. We read through the notes. What struck us is that they are not endorsing a brand, they are endorsing the same two things this review keeps landing on: a dose that matches the trial, and a company that publishes the certificate before anyone asks. A cardiologist in Ohio put it in one line: almost nothing on the shelf matches it in either direction.
There is also a point worth making in a category this loud: this is the only third party verified product in the review. Not a badge on a bottle. An actual batch document with a measured assay result printed beside the label claim. We asked all five companies for one. Four could not produce it. One published it before we asked.
What it is not: fast, or cheap. Circulation compounds over roughly twelve weeks and the brand says so on its own page rather than letting buyers discover it. Sixty capsules, two a day, thirty days. It contains soy, because nattokinase is fermented from soybeans, and anyone taking an anticoagulant should speak to their prescriber before adding it. All three of those facts are on their label, which is more than we can say for most of what follows.
372 clinicians share this on FrontrowMD without compensation.
Gordon Mayhew, MD
Cardiology · Columbus, OH
I share it for the dose. 10,800 FU is the figure the twelve-month trial actually used, and almost nothing on the shelf matches it in either direction.
Priya Raghunathan, MD
Internal Medicine · Scottsdale, AZ
Nearly every patient I see over 60 is on a statin, and nothing they take replaces the CoQ10 it depletes. This does, at a dose that is not decorative.
Stephen Nakamura, MD
Vascular Medicine · Sacramento, CA
Fibrinolysis slows with age because PAI-1 climbs, not because the enzyme runs out. This is one of the few formulas built around that distinction.
Karen Whitfield, PharmD
Clinical Pharmacy · Des Moines, IA
I flag the K2 for anyone on warfarin, and I appreciate that the label raises it before I have to. That is rarer than it should be.
Marcus Ellery, DO
Family Medicine · Chattanooga, TN
I ask every company for a certificate of analysis. This is one of the very few that publishes one before I think to ask.
Lorraine Boyd, MD
Preventive Cardiology · Raleigh, NC
I tell patients to give it twelve weeks and keep a written log. It is not fast, and I would rather work with a company that says so up front.
FrontrowMD verifies clinician identity and licensure. Clinicians are not paid to share this product.
We want to be careful here, because Double Wood does not deserve to be lumped in with what comes after it. If every company in this category behaved the way Double Wood behaves, this article would not need to exist.
They print the FU on the front. They print the milligrams underneath it, in the correct order of importance. They do not run a countdown timer. They do not claim a month is 84% sold out. Nothing on their page overstates what the capsule does. In a category where two brands further down this page invent statistics, a company that simply describes its product accurately is worth something real.
What we could not get was a certificate. We asked all five companies in this review for a batch specific Certificate of Analysis showing measured enzyme activity against the label claim. Double Wood was courteous about it and pointed us at general testing language. That is not the same document. Of the five products here, exactly one produced a third party verified batch certificate we could read, and it was not this one. Which matters more here than it would elsewhere, because independent testing has already found three of eight nattokinase products on the open market missing their own label claim.
It loses on one thing, and it is the thing this review is about. 4,000 FU is 37% of the dose that produced measurable plaque regression over twelve months, and it sits just 400 FU above the dose the same study tested and found did nothing at all. That is an uncomfortably narrow margin to build a heart protocol on. Nobody has ever run a twelve month outcome trial at 4,000 FU. The nearest data point below it is a documented null result.
The second issue is scope. This is one enzyme, doing one job, well. It has nothing to say about your blood pressure, nothing to say about where the calcium in your artery wall is going, and nothing to put back what your statin is taking out. That is not a criticism of the company. They never claimed otherwise. It is a description of what you would be buying.
If you are already committed to standalone nattokinase and you want the version made by the company least likely to disappoint you, this is it. Just be clear about what you are getting: a well run company selling a serious ingredient at a dose the research has not validated.
We have reviewed a lot of supplement pages. We have never seen one quite like this.
Maïa’s nattokinase page is a ceremonial cocoa page with the word nattokinase typed over the top of it, and nobody finished the job. These are not old cached versions. They were on the live page on 4 August 2026, on a product sold as a bottle of thirty capsules:
“10X more artery-supporting flavanols than regular cocoa”Directly beneath the product headline
“MAIA uses ultra-rare criollo cacao beans, the most prized variety in the world.”Under the heading “The Science Behind MAÏA Nattokinase Benefits”
“Simply mix one scoop with hot water or your favorite milk. Stir well and enjoy! It tastes like rich, ceremonial hot chocolate.”On a capsule product
“Melt cacao in a saucepan over low heat.”Step one of the section titled “How To Take MAÏA Nattokinase”
Their per-serving breakdown lists epicatechin, theobromine and magnesium. It does not mention nattokinase at all. Their comparison table ranks Maïa against Super Cacao, Beetroot Powders and Pomegranate Juice. Their own FAQ asks “How is MAÏA different from regular nattokinase supplements?” and answers it with a paragraph about cocoa beans.
Then there is the dose claim, which is the part that actually matters. Maïa runs a section headed “#1 Supported by Clinical Research”, prints “12 Month Study” and “1062 Adults” beside it, and states that their 5,000 FU is “the potency level used in leading nattokinase research.”
It is not. That study tested 10,800 FU and 3,600 FU. There was no 5,000 FU arm. Maïa has cited, by participant count and duration, the one paper that establishes their dose was never tested.
And then there are the customers. Maïa’s public rating is 2.5 out of 5, from an unclaimed profile, with 100% of published reviews at one star.
“I purchased buy 2, get 2 and added 9 additional bags at checkout for $157.50. I received 4. Maïa customer care insists the package was delivered and has given me 2 addresses where it was supposedly delivered, neither of which is the address that is on the order. Theft. Dishonesty.”Reviewer, 6 April 2026. Maïa’s public reply cited a tracking number for an address in a different state.
“Ships from China! Never arrives! I ordered in December. Weeks later I received notice that the product was shipping from China of all places. I still have not received the shipment and I get no response to multiple requests for a refund.”Reviewer, 28 February 2026
“I placed an order today and I am yet to receive a confirmation email of purchase. I have left umpteen messages and no response. Concerned!”Reviewer, 17 March 2026
Retrieved 4 August 2026. Every published review on the profile is one star.
The page also carries a sold-out month, an 84% reserved month and a “next restock” month, all hardcoded to a spring calendar that has long since passed, alongside a delivery promise for a date in March. Underneath the buy buttons, in smaller type, sit the words “Refills Ship Every 30 Days.”
Verdict. A product whose own sales page cannot decide whether it is a capsule or a hot drink, citing a study that disproves its dose, with a one-star public review record and no certificate. The bottle may well contain 5,000 FU of something. There is no document on earth that will tell you.
Nutricost places fourth, and it is the only company in the bottom half of this review we have nothing bad to say about.
That sentence should tell you exactly how this ranking works. Nutricost do not run a countdown timer. They do not claim a study said something it did not say. They do not attach a subscription to the button and hope you miss it. Their label is plain and legible and tells you what is in the bottle: 2,000 FU per serving, 120 capsules, 120 servings, soybeans on the front. If we were ranking companies, they would place second.
We are not ranking companies. We are ranking whether the capsule can do the thing you are buying it to do.
2,000 FU is not a smaller version of the dose that worked. It sits below the dose that was tested alongside it and produced nothing at all.
The 1,062 person trial ran 3,600 FU as its low arm. That arm returned no meaningful effect on lipids and no suppression of plaque progression over twelve months. Nutricost’s serving is 44% of that failed arm and 18.5% of the dose that worked. To reach 10,800 FU on this label you would need to take five and a half servings a day, which would empty the bottle in three weeks and is not what anybody is doing.
This is also why the value score is low despite it being the cheapest bottle here. A low price on a capsule that the published record says will not move anything is not a saving. It is a smaller monthly amount, spent for longer, on the same nothing. This is the most common mistake buyers make in this category, and it is completely rational: the bottle costs less, the ingredient is real, the company is honest. Every part of that is true and the arithmetic still does not work.
The second issue is the same one that limits #2. One ingredient reaches one of four mechanisms. Nothing here touches blood pressure, calcium routing, or the CoQ10 your prescription is removing.
Verdict. The most honest company in this review is selling the least useful bottle in it. If you have already bought it, you have not been cheated, and you have not been helped either. Take it to the number that was actually studied, or take something that gets there.
Corvael gets one sentence of credit and we are going to give it now, because it is the only sentence it earns. On paper, this is the most ambitious formula in the review. Five actives, aimed at real mechanisms, every dose printed rather than buried in a blend. Somebody at that company understands cardiovascular medicine.
Here is why that is worth almost nothing.
You cannot buy a formula on paper. You buy what is in the capsule. And there is no document anywhere that will tell you what is in this capsule. We asked. A customer asked, repeatedly, in public, and published the outcome: “I asked for the lab documents and they said it’s online, it is not. Their website specifically says available upon request. So I requested them, multiple times. No lab document ever produced.” Coverage you cannot verify is not coverage. It is a list of ingredient names.
The dose. 20,000 FU. That is 85% above the highest dose ever carried through a twelve month human outcome trial. Their own FAQ positions the product against “Amazon’s 10,000 FU products”, as though 10,000 were the low end. There is no trial above 10,800. There is no trial at 20,000. There is a number chosen because it is bigger than the other numbers on the shelf.
The statistic. Corvael’s page states your vascular system “loses 60% of its natural fibrinolytic capacity by age 60.” We went looking for it. The literature describes something different and better documented: fibrinolysis becomes impaired with age because PAI-1, the body’s own brake on the clearing system, rises. There is no 60% figure. We could not source it, and neither, as far as we can tell, can they. Their page also claims nattokinase is “8x more active” than plasmin, where the literature generally puts it around fourfold.
The safety line, which is the one that alarms us. Corvael’s comparison table tells the reader their product is a “natural fibrinolytic, no bleeding risk, no dependency” and that it “dissolves fibrin without thinning your blood like Eliquis or warfarin.” This is sold to people on anticoagulants. A fibrinolytic enzyme is not a compound you tell that audience carries no bleeding risk. Their headline testimonial has a named customer coming off Eliquis, and the same customer’s story appears twice on the same page in two contradictory versions: once as having switched while on Eliquis, once as having come off it.
And the ingredient they argue for and do not sell. Corvael runs a five step explainer on their own page. Step four is titled The Statin Trap: “Statins lower cholesterol by depleting CoQ10, the exact fuel your heart muscle runs on.” They are right. It is the best argument on their website.
There is no CoQ10 in Corvael. They wrote the case for an ingredient, to a readership largely on statins, and then sold a bottle without it.
Then we read the customers, and the review stopped being about a formula. Corvael’s parent brand holds a public score of 2.6 out of 5 across 107 reviews, on a claimed profile the platform flags as not having replied to its negative reviews. The platform’s own summary of the corpus cites items “not matching advertised ingredients”, misspellings on packaging, postage problems and non-receipt of packages.
“They loudly proclaim their 100%, no hassle, no questions asked, keep the bottle, no return required, refund within 48 hours if you aren’t satisfied. They refused to abide by their guarantee, replying that I must return the bottles, that they must be unopened, and returned at my expense.”Reviewer, 28 July 2026. The same review reports a $7.99 shipping insurance charge added without opt-in, which they were told could not be reversed because the order had shipped. Tracking later showed the label had not been printed until two days after that reply.
“Day 31. As far as I can tell, since the communication from this company is non-existent, it is still in China. Had I known that this product Corvael was made in China I would never have purchased it.”Reviewer, 22 July 2026
“I tried the new capsules knowing they advertise a 90 day no questions asked, no returns necessary. The no returning of product is a bald faced lie. I returned the merchandise, sent a screenshot of the receipt. They still found a way not to refund me, so now I don’t have the capsules or my refund.”Reviewer, 21 July 2026
“Set up a subscription and even when they agree to cancel, they still send a notification for shipping so they can justify not giving you all your money back.”Reviewer, 8 March 2026
“They used counterfeit postage to ship my order. The return address on the package was a hotel in Minneapolis according to Google Maps.”Reviewer, 8 July 2026. A second customer reports USPS confiscated their package for the same reason.
Retrieved 4 August 2026. Note the guarantee lengths quoted by customers: one was sold a 90 day policy, another cites 120 days, and the product page today states 30. We found no version that matched what buyers said they were promised.
Verdict. The best formula in this review on paper and the worst product in it in practice, and those two facts are not in tension. A dose past where the evidence stops, a headline statistic that does not exist, a bleeding-risk claim aimed at exactly the audience that must not hear it, an ingredient argued for and omitted, a guarantee that changes depending on who is asking, and a company whose customers describe counterfeit postage and packages that never arrive. Finishing last here is not close.
Nine things that separate a verified, complete circulation formula from a bare capsule. Every tick below is earned by something stated in the reviews above.
| BlueOrganics#1 | Double Wood #2 |
Maïa #3 |
Nutricost #4 |
Blissta Corvael #5 |
|
|---|---|---|---|---|---|
| Matches the 10,800 FU studied dose | ✓ | – | – | – | – |
| Above the 3,600 FU arm that failed | ✓ | ✓ | ✓ | – | ✓ |
| Exact FU disclosed on the label | ✓ | ✓ | ✓ | ✓ | ✓ |
| Third party verified batch certificate | ✓ | – | – | – | – |
| Protected delivery, liposomal or enteric | ✓ | – | – | – | – |
| Addresses blood pressure | ✓ | – | – | – | ✓ |
| Addresses calcium routing with K2 | ✓ | – | – | – | ✓ |
| Contains CoQ10 | ✓ | – | – | – | – |
| Guarantee honoured as written, per public reviews | ✓ | ✓ | – | ✓ | – |
Swipe to compare all five
Every other product in this review gets one or two of these right. This is the only one that gets all six.
10,800 FU, matched to the dose that produced measurable plaque regression across 1,062 people over twelve months. Not rounded up for the front of the bottle. Not doubled to win a shelf argument. It is the only product here where the number on the label and the number in the literature are the same number.
Nattokinase is a protein and proteins are fragile in stomach acid. Every other bottle in this review answers that problem by adding more enzyme and hoping. This one answers it with liposomal encapsulation, which protects the dose rather than inflating it. Nobody else in this category is competing on this at all.
Four mechanisms drive arterial decline and they run independently. Fibrin clearance and the PAI-1 brake. Blood pressure through nitric oxide. Calcium routing through K2. Metabolic and mitochondrial support. Four of the five products here address one of the four. Corvael reaches three. This one is the only bottle that reaches all four, and the fourth one is the one your prescription is working against.
We asked all five companies for a batch certificate. Four of them do not have one you can read. One published a retrievable document with the measured assay result printed next to the label claim, before anybody asked. Not a badge. Not a “third party tested” graphic on a bottle. A document, with a number on it, that you can check against the product you receive. In a category where independent testing found three of eight products missing their own label claim, that is the difference between a number and a fact.
Every product in this category has a marketing department. This is the only one in our review with 372 named, licensed clinicians attached to it on a platform that verifies them and states they are not paid. That is not proof the product works. It is proof that people who read labels for a living looked at this one and were willing to put their name next to it, which is a different and useful signal.
This is the one we did not expect to be writing. Their own page tells you the first three weeks will feel like nothing. It tells you the arc runs about twelve weeks. It tells you to speak to your prescriber before adding it if you take an anticoagulant, and it tells you not to stop anything. In a category where a competitor is telling a medicated audience there is no bleeding risk, a company that volunteers its own inconvenient facts is doing something worth paying for.
Keep these. They will outlast this article, and they work on any bottle you pick up anywhere.
If the front of the bottle leads with milligrams and buries the FU, or omits it entirely, the manufacturer is describing the weight of the powder rather than the strength of the enzyme. Those are not the same measurement and only one of them matters.
Under it and you are in a band that was tested and produced nothing. Far over it and you are somewhere no twelve month human trial has ever been. Both directions are guesses. Only one of them is a guess that also sounds impressive.
The most useful footnote in this entire category. It means the number was true the day it left the factory and nobody has promised anything about the day it reached you. Enzymes lose activity in storage. This phrase is how a label stays technically accurate while telling you nothing.
Check whether the FU figure is per capsule or per serving, and how many capsules a serving is. A bottle claiming a big number across four capsules is a smaller bottle than it looks.
Enteric coating, liposomal encapsulation, or nothing. If the label is silent, the answer is nothing, and a share of what you paid for does not survive the stomach.
A badge is graphic design. A certificate is a document with a batch number, an assay method and a result. If a company will not produce one when asked directly, treat the badge as decoration. Four of the five companies in this review failed exactly this test.
“Dissolves existing clots”, “unclogs arteries”, “dissolves sticky deposits”, “no bleeding risk”. Fibrinolytic activity is documented. Clot dissolution in humans at supplement doses is not, and no supplement is permitted to promise it. Two products in this review use language from that list, and one of them aims it at people taking anticoagulants. A brand willing to overstate what the capsule does is telling you what it will do with the numbers as well.
Before you spend anything, in this category or any other, run the bottle against this list.
Activity, not weight. If it is not on the front, ask why.
The only dose with twelve months of human outcome data behind it. Above it, nobody has checked.
NSK-SD or another named standardised form, so there is a defined material behind the number.
Liposomal or enteric coated. Silence means unprotected, and the enzyme is fragile.
Retrievable before purchase. If it is “available on request”, make the request before you order and see what happens.
One sentence that quietly withdraws the promise on the front of the bottle.
Read the button, not the headline. Check the refund terms and whether returning an opened bottle is required. Several companies in this category promise one policy on the sales page and enforce another by email.
Third party listings in this category are where mislabelled and expired stock accumulates, and where the certificate trail ends.
No single compound is a magic bullet, and anybody who tells you otherwise is selling harder than the evidence allows.
What the record supports is narrower and more useful than the marketing. At the studied dose, over twelve months, in 1,062 people, carotid plaque decreased and intima media thickness fell. In a separate meta analysis of six randomised trials covering 546 participants, nattokinase produced average reductions of 3.45 mmHg systolic and 2.32 mmHg diastolic. Modest, replicated, real. The same analysis found that at low total dosage the picture changed for the worse, which is one more argument for taking the dose question seriously.
The timeline is the part most people are not told. The first three weeks usually feel like nothing at all. That is the fortnight where most people quit, and it is worth knowing in advance rather than discovering it. Small physical changes tend to show up somewhere between weeks three and six: warmer hands and feet, less swelling in the ankles after a long drive or a flight, a chest that feels calmer. The numbers on a chart move later, closer to the twelve week mark.
That is why the honest way to buy this is in a run long enough to answer the question. One bottle is thirty days of a twelve week arc. It will tell you almost nothing.
And the thing nobody in this category will say plainly: if you are on an anticoagulant, ask your prescriber first. Nattokinase has fibrinolytic activity and so does your medication. If you are on warfarin specifically, note that vitamin K is warfarin’s antidote and appears in some of these formulas, so K intake is not something to change quietly. The newer anticoagulants do not work through the vitamin K pathway and do not share that particular interaction. None of this is a reason to avoid the category. It is a reason to have one short conversation before you start.
After we published our first round of findings, the team at BlueOrganics saw the response and got in touch. I was direct with them.
“Yours is the only bottle in the review where the label and the study agree, and the only one that produced a certificate when we asked. But a lot of my readers are on a fixed income, and right now they are spending forty and fifty dollars a month on a dose the research already tested and found did nothing. They cannot tell the difference yet. That is not their fault.”
After some back and forth, they agreed to something they do not normally do. Readers of this review get bundle pricing, and both of their guides included free with every order rather than sold separately.
One note on why their guarantee is shorter than some of the ones in this review. Length is not the measure. A 120 day guarantee that requires unopened bottles returned at your own expense is worth less than a 30 day one that requires nothing. We would rather publish the short honest number.
Liposomal Nattokinase 10,800 FU · 60 capsules · 2 daily · 30 day supply
The trial that anchors this review ran for twelve months. Nobody is asking you to buy twelve months. But five bottles is 150 days, which is the closest any of these packages gets to the length of time the research actually measured.
Check Availability →30 day
guarantee
No return
required
Batch COA
published
We asked what happened after people read the first version of this article. Almost none of the replies were about a supplement.
“I printed the section about the two doses and took it to my appointment. My cardiologist read the whole thing standing up, then sat down. He wrote two things on the back of an appointment card and told me to bring it back in three months.”
Patricia, 67, Ohio“I have been on a statin for eleven years and nobody has ever explained the CoQ10 thing to me. I am not angry about it. I just did not know there was a question to ask.”
Frank, 71, Arizona“I had 2,000 FU in the cupboard. I had been taking it for two years and telling my wife it was working. Reading the part about the failed arm of that study was not a nice afternoon.”
Raymond, 66, Michigan“The three words did what you said they would do. It was the first appointment in years where I did most of the talking.”
Eleanor, 69, Florida
Of the five best selling nattokinase products in America, one matched the dose the research used, one protected the enzyme on the way through, one reached all four mechanisms of arterial decline, and one produced a certificate when we asked for it. They were the same product.
Now the part we care about more than the ranking.
We are not telling anyone to discontinue a medication, and nothing in this article should be read that way. Your blood pressure prescription is doing its job. Your anticoagulant is preventing the next clot. Keep taking them. Speak to your prescriber before adding anything with fibrinolytic activity, and tell them exactly what it is.
Ask what is being done about fibrinolytic activity, calcium routing, and PAI-1.
Use those three words. You do not need to know more than we have told you here. Watch what happens to the pace of the conversation.
The average patient gets about eleven seconds before the first interruption. Those three words are eleven seconds well spent.
Made in
U.S.A.
30-Day
Guarantee
Free
Shipping
* Results are based on our Subjective Ranking System and do not necessarily reflect typical results from the use of these products. Scores are editorial judgements against the criteria described above, with Dose Fidelity and Mechanism Coverage double weighted. Product doses are the manufacturers' own stated label claims. Please visit product websites for current information.